These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28535647)

  • 1. [Effects of overexpression of miR-17-92 gene cluster on the biological characteristics of prostate cancer cells and its mechanism].
    Zhou P; Ma L; Zhou J; Xu JJ; Liu F; Guo F
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):325-331. PubMed ID: 28535647
    [No Abstract]   [Full Text] [Related]  

  • 2. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crypotanshione reduces the expression of metadherin in DU145 prostate cancer cells].
    Yao Y; Li HZ; Qian BJ; Liu CM; Zhang JB; Lin MC
    Zhonghua Nan Ke Xue; 2015 Sep; 21(9):782-7. PubMed ID: 26552209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyoxometalate SbW9 regulates proliferation and apoptosis of NSCLC cells via PTEN-dependent AKT signaling pathway.
    Sun HB; Xu L; Wang ZX; Zheng Y; Zhao Y; Yin YY; Han XL; Xu ZN
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7959-7967. PubMed ID: 31599421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of miR-21 on hypertensive rats through PTEN/PI3K/Akt/mTOR signaling pathway.
    Shi YJ; Xu W; Han YF; Li JX; Niu LL; Chen YD
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4924-4931. PubMed ID: 31210327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21.
    Zhou B; Wang J; Zheng G; Qiu Z
    Food Chem Toxicol; 2016 Nov; 97():375-384. PubMed ID: 27725205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5.
    Zhu L; Zhu Q; Wen H; Huang X; Zheng G
    J Cell Physiol; 2019 Jun; 234(6):8928-8940. PubMed ID: 30317620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway.
    Guo LP; Zhang ZJ; Li RT; Li HY; Cui YQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):253-261. PubMed ID: 30657567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
    Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
    Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
    Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells.
    Li W; Jiang Y; Wu X; Yang F
    Cancer Biother Radiopharm; 2019 Sep; 34(7):480-485. PubMed ID: 31135180
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.
    Ohigashi T; Mizuno R; Nakashima J; Marumo K; Murai M
    Prostate; 2005 Jan; 62(1):61-8. PubMed ID: 15389810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
    Kimbrough-Allah MN; Millena AC; Khan SA
    Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY; Cui JH; Liang S; Li HL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.